FDA Inspection
VitalantVitalant – FDA Inspection, May 4, 2022
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on May 4, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- May 4, 2022
- Product Type
- Biologics
View Company Profile
ID · deb7b573-9236-46e5-8acf-22c063f05fd5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1169287
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 17, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 8, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 1, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 23, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1079968 - 2019-02-05
- FDA Inspection 998464 - 2017-01-17
- FDA Inspection 877417 - 2014-04-08
- FDA Inspection 780542 - 2012-05-01
- FDA Inspection 614245 - 2009-09-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.